Product
Enriched Hematopoetic Stem Cell
1 clinical trial
8 indications
Indication
AnaemiaIndication
Sickle CellIndication
HemoglobinopathiesIndication
ThalassemiaIndication
Diamond-Blackfan AnemiaIndication
Bone Marrow Failure SyndromesIndication
Alpha-thalassemiaIndication
Beta ThalassemiaClinical trial
Phase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesStatus: Withdrawn, Estimated PCD: 2016-05-01